[go: up one dir, main page]

Lainson et al., 2017 - Google Patents

Synthetic antibacterial peptide exhibits synergy with oxacillin against MRSA

Lainson et al., 2017

View HTML
Document ID
7163970907559007319
Author
Lainson J
Daly S
Triplett K
Johnston S
Hall P
Diehnelt C
Publication year
Publication venue
ACS Medicinal Chemistry Letters

External Links

Snippet

One proposed solution to the crisis of antimicrobial resistant (AMR) infections is the development of molecules that potentiate the activity of antibiotics for AMR bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Rather than develop broad spectrum …
Continue reading at pmc.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Similar Documents

Publication Publication Date Title
Lainson et al. Synthetic antibacterial peptide exhibits synergy with oxacillin against MRSA
Lakemeyer et al. Thinking outside the box—novel antibacterials to tackle the resistance crisis
Yarlagadda et al. Glycopeptide antibiotic to overcome the intrinsic resistance of gram-negative bacteria
McCarthy et al. Phage display of dynamic covalent binding motifs enables facile development of targeted antibiotics
Yang et al. A tobramycin vector enhances synergy and efficacy of efflux pump inhibitors against multidrug-resistant Gram-negative bacteria
Ji et al. Iron transport-mediated drug delivery: practical syntheses and in vitro antibacterial studies of tris-catecholate siderophore–aminopenicillin conjugates reveals selectively potent antipseudomonal activity
LaMarche et al. Discovery of LFF571: an investigational agent for Clostridium difficile infection
Wang et al. The therapeutic effect of chlorogenic acid against Staphylococcus aureus infection through sortase A inhibition
Knappe et al. Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens
Harris et al. Small molecule downregulation of PmrAB reverses lipid A modification and breaks colistin resistance
Vila-Farrés et al. Combating virulence of Gram-negative bacilli by OmpA inhibition
Ball et al. Conjugating berberine to a multidrug resistance pump inhibitor creates an effective antimicrobial
Chou et al. Synthetic peptides that form nanostructured micelles have potent antibiotic and antibiofilm activity against polymicrobial infections
Jammal et al. Sensitization of Gram-negative bacteria to rifampin and OAK combinations
Chu et al. Synthesis and bioactivities of new membrane-active agents with aromatic linker: high selectivity and broad-spectrum antibacterial activity
Yamauchi et al. Development of Antimicrobial Peptide–Antibiotic Conjugates to Improve the Outer Membrane Permeability of Antibiotics Against Gram-Negative Bacteria
Feigman et al. Synthetic immunotherapeutics against Gram-negative pathogens
‘t Hart et al. New insights into nisin’s antibacterial mechanism revealed by binding studies with synthetic lipid II analogues
Chen et al. A marine antibiotic kills multidrug-resistant bacteria without detectable high-level resistance
Pereira et al. Peptide targeting of an antibiotic prodrug toward phagosome-entrapped mycobacteria
Chan et al. Selective permeabilization of gram-negative bacterial membranes using multivalent peptide constructs for antibiotic sensitization
Johnson et al. Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections
Johnson et al. Inhibition of isoleucyl-tRNA synthetase by the hybrid antibiotic thiomarinol
Fritsch et al. Uptake mechanisms and regulatory responses to MECAM-and DOTAM-based artificial siderophores and their antibiotic conjugates in Pseudomonas aeruginosa
Szałaj et al. Bacterial type I signal peptidase inhibitors-Optimized hits from nature